C Chandra Bhagat Pharma Limited has submitted a formal communication to The BSE Limited, specifically addressed to the Manager - Listing Compliance, Department of Corporate Service. The subject of the communication is a certification regarding the non-applicability of corporate governance requirements for the quarter ended June 30, 2026.
The basis for this exemption is Regulation 15 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation stipulates that compliance with specific corporate governance provisions (Regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27 and clauses (b) to (i) and (t) of sub-regulation (2) of Regulation 46 and para C, D and E of Schedule V) is not mandatory for two categories of entities:
1. Listed entities with a paid-up equity share capital not exceeding ₹10 crore and a net worth not exceeding ₹25 crore as of the last day of the previous financial year.
2. Listed entities that have listed their specified securities on an SME Exchange.
The company states that it qualifies for the exemption under the second category, as it has listed its specified securities on an SME Exchange. Consequently, the compliance with the aforementioned corporate governance provisions is not applicable to the company.
The letter concludes by formally stating that the company is not required to submit a Corporate Governance Report for the quarter ended June 30, 2026, and requests the exchange to take this information on record.